Logo

Decode Shares Up 10 Percent as Bank Upgrades Stock

Mar 08, 2007
NEW YORK (GenomeWeb News) — Shares in Decode Genetics were up 10 percent, or $.35, at $3.87 after the stock was upgraded by an investment bank
 
Lehman Brothers upgraded the stock to "equal-weight" from "underweight."
 
Decode yesterday reported that fourth-quarter revenues increased 17 percent as R&D spending rose 4 percent and lossed increased 10 percent. 
Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.